Women with PCOS had higher levels of the pro-inflammatory macrophage-derived biomarkers CXCL5, CD163, and matrix metalloproteinase 9 (MMP9), but CD200 expression was lower. The gene discussed is MMP9; the disease is polycystic ovary syndrome.